A bioengenharia tecidual tem sido aplicada na Endodontia na busca de tratamentos mais biológicos. A revascularização pulpar tem sido observada em dentes com ápice aberto, porém há poucos estudos direcionados aos dentes com ápice formado. A angiogênese é primordial para a nutrição celular durante a regeneração tecidual. O objetivo deste estudo foi analisar o efeito do fator de crescimento endotelial (VEGF) na angiogênese após pulpectomia de canais radiculares de rato com apicigênese completa. A câmara pulpar dos primeiros molares superiores de 12 ratos machos Wistar com 13 semanas foi acessada. A polpa radicular do canal mésio vestibular foi removida e o canal instrumentado até a lima K25. Com uma lima K20, além do limite foraminal, foi induzido o sangramento periapical para o canal radicular. Os dentes do lado direito da arcada foram preenchidos com coágulo sanguíneo (GS), e nos dentes do lado esquerdo foi utilizado VEGF165 recombinante (Prospec, Israel) adicionado ao coágulo (GV). Os dentes foram selados com ionômero de vidro fotopolimerizável, e 60 dias depois os animais foram sacrificados. A maxila foi dissecada, fixada, descalcificada e incluída em parafina. Cortes transversais seriados foram feitos e corados com hematoxilina-eosina para avaliação morfológica ou incubados com anticorpo de coelho anti-fator VIII (Bioss, EUA) para análise da angiogênese. A análise histológica demonstrou canais preenchidos por tecido conjuntivo sem presença de odontoblastos nos dois grupos. A imuno-histoquímica demonstrou positividade para o anticorpo no tecido neoformado em ambos os grupos. No grupo 1 foi predominante a marcação difusa, e no grupo 2 foi a marcação definida. Pode-se concluir que o uso de VEGF acelera a angiogênese que ocorre em canais pulpectomizados de molares com apicigênese completa. / The tissue engineering has been applied in Endodontics in search of more biological treatments. The pulp revascularization has been observed in immature teeth, but there are few studies directed to the closed-apex teeth. Angiogenesis is essential for cellular nutrition during tissue regeneration. The aim of this study was to analyze the effect of vascular endothelial growth factor (VEGF) in angiogenesis after pulp removal in rats with mature teeth. The pulp chamber of upper first molars of 12 male Wistar rats with 13-weeks-old was accessed. The pulp of the mesiobuccal root canal was removed, and the root canal was shaped up to 25K-file. Then, a 20K-file was introduced beyond the apex to induce bleeding. The teeth on the right side of the arch are filled using blood clot alone (GS) and the teeth on the left side was filled using blood clot + VEGF165 recombinant (Prospec, Israel) (GV). The teeth were coronally sealed using light-curing glass ionomer, and the animals were sacrificed after 60 days. The samples were dissected, fixed, decalcified and included in paraffin. Transverse serial sections were made, and stained using hematoxylin-eosin to morphological evaluation or expressed by immunostaining using anti-Factor VIII rabbit antibody (BIOSs, USA) to angiogenesis analysis. Morphological analysis showed root canals filled by connective tissue without the presence of odontoblasts in both groups. Immunohistochemistry showed positivity for the antibody in the new tissue in both groups, with marking defined in group 2. Diffuse marking was predominant in the group 1, and the well-maked type was predominant in the group 2. It can be concluded that the use of VEGF accelerates angiogenesis that occurs in root canal of closed-apex molars after pulpectomy.

A formação de novos vasos sanguíneos é fundamental para o crescimento tumoral e a disseminação metastática, sendo o fator de crescimento endotelial vascular (VEGF) uma das chaves reguladoras deste processo. O objetivo do presente estudo foi avaliar a expressão imunohistoquímica de VEGF nos hemangiossarcomas e hemangiomas esplênicos, e rever a prevalência das demais afecções esplênicas através da análise retrospectiva do diagnóstico histopatológico de cães submetidos à esplenectomia. Os resultados foram confrontados com os exames laboratoriais, as manifestações clínicas, a presença de arritmias cardíacas e de hemoperitôneo. Participaram do estudo retrospectivo 109 cães atendidos no Serviço de Cirurgia de Pequenos Animais do Hospital Veterinário da Faculdade de Medicina Veterinária e Zootecnia da Universidade de São Paulo, entre os anos de 2002 e 2009. A média de idade foi de 10 anos (± 3), não foi observado predileção sexual. Cães sem raça definida foram os mais acometidos, com peso médio de 22 kg (± 13). Cinqüenta e dois por cento (57/109) dos animais foram esplenectomizados devido a afecções não neoplásicas, enquanto que 48% (52/109), por neoplasias esplênicas. Dentre estes, o diagnóstico mais freqüente foi o hemangiossarcoma, acometendo 28 (54%) animais. Os sintomas mais freqüentes foram disorexia, apatia e emese. Cães com neoplasias malignas apresentaram níveis de hematócrito e hemácias significativamente menores que os acometidos por massas benignas. Do mesmo modo, a presença de hemoperitôneo, secundário à ruptura esplênica, correlacionou-se significativamente com a presença de neoplasia maligna. Arritmias cardíacas não foram fatores preditivos para a diferenciação da esplenomegalia. A avaliação imunohistoquímica da expressão tecidual de VEGF foi realizada em 23 hemangiossarcomas e 7 hemangiomas, revelando-se significativamente maior nas neoplasias malignas. Tal resultado sugere que a expressão deste fator pode estar relacionada à proliferação maligna observada nos hemangiossarcomas. / New blood vessel formation is a fundamental event in the process of tumor growth and metastatic dissemination, being the vascular endothelial growth factor (VEGF) one of the key regulators of this process. The aim of this study was evaluate the VEGF immunohistochemical expression in splenic hemangiosarcomas and hemangiomas, and review the prevalence of canine splenic disorders through retrospective analysis of histological diagnosis after splenectomy. The results were confronted with laboratory findings, clinical signs and presence of cardiac arrhythmia and hemoperitoneum. A hundred nine dogs were included in the retrospective study at Veterinary Hospital of School of Veterinary Medicine, University of Sao Paulo, between 2002 and 2009. The average age was 10 year ± 3, without sexual predilection. Mix breeds were the most frequent, and average weigh was 22kg ± 13. Overall, 52% (57/109) of dogs were splenectomized for nonneoplastic disease, although 48% (52/109) were splenectomized for neoplasia. Among these dogs the most common diagnosis was hemangiossarcoma (28 dogs, 54%). Frequently clinical signs included anorexia, lethargy and vomiting. Dogs with malignant neoplasia had significantly lower red blood cells counts and packed cell volume compared with values for dogs with benign masses. Similarly, hemoperitoneum secondary to splenic rupture had a significant correlation with malignant tumor. Cardiac arrhythmia was not useful in differentiating dogs with splenomegaly. Expression of vascular endothelial growth factor was made by immunohistochemical analyses in 23 hemangiosarcomas and 7 hemangiomas being significantly higher in malignant tumor. These data suggest that VEGF expression may contribute to malignant proliferation of hemangiossarcoma.

Orientador: Maria Alice da Cruz Hofling / Dissertação (mestrado) - Universidade Estadual de Campinas, Faculdade de Ciências Médicas / Made available in DSpace on 2018-08-22T15:24:51Z (GMT). No. of bitstreams: 1 Mendonca_MoniqueCulturatoPadilha_M.pdf: 7402848 bytes, checksum: 64244a22fab0eb94170d857f28da8e50 (MD5) Previous issue date: 2013 / Resumo: O fator de crescimento endotelial vascular (VEGF), o principal regulador da angiogênese e da permeabilidade vascular, foi recentemente reconhecido como neurotrófico, neurogênico e neuroprotetor, sendo, portanto, regulado positivamente em muitos processos neuropatológicos. Neste modelo experimental de quebra da barreira hematoencefálica (BHE) pelo veneno da aranha Phoneutria nigriventer (PNV), a expressão do VEGF e seus receptores tirosina-quinase, Flt-1 e Flk-1 e de seus RNAs mensageiros foi investigada no hipocampo e cerebelo de ratos Wistar (Rattus norvegicus) por imunohistoquímica (IHQ), western blotting (WB) e reação em cadeia da polimerase em tempo real (qPCR). Paralelamente, a integridade da BHE foi avaliada através da expressão das proteínas da via paracelular, Ocludina e ?-catenina, e da principal proteína da membrana basal, a Laminina, que estão presentes no endotélio na interface sangue-cérebro. O estudo foi realizado em ratos de 14 dias (neonatos) e de 8-10 semanas (adultos jovens) para avaliar diferenças em função da idade na funcionalidade da BHE e na possível mediação dos efeitos neurotóxicos do PNV pelo VEGF. A via escolhida para administração de PNV (1,7 mg/kg em 0,5ml de salina 0,9%) foi intraperitoneal, devido sua administração mais favorável nos animais neonatos. Os tempos de 2, 5 e 24 horas após a administração de PNV visaram investigar a expressão das proteínas, RNAs mensageiros e uma possível mediação pelo VEGF na fase aguda do envenenamento. A administração do PNV provocou sinais imediatos de intoxicação nos animais, os quais foram mais severos e imediatos nos neonatos do que nos adultos. No hipocampo, os dados do WB mostraram aumento da expressão de VEGF, Flt-1 e Flk-1 e respectivos RNAs mensageiros, que foram concomitantes com o desenvolvimento de edema perivascular e diminuição da expressão da Ocludina, ?-catenina e Laminina. Os dados da IHQ mostraram que a imunorreatividade de VEGF ocorreu nos corpos dos neurônios piramidais e dendritos nos subcampos CA1, CA2, CA3 e giro denteado do hipocampo, em contraste com a marcação nuclear de Flt-1 e Flk-1. O PNV aumentou visivelmente a imunomarcação das três proteínas. No cerebelo, os dados do WB e IHQ mostraram que o PNV induziu aumento na expressão dos componentes do sistema VEGF/Flt-1/Flk-1. Células presentes na camada granular e molecular que não mostraram marcação nos animais controles passaram a ser positivas nos animais xviii envenenados, principalmente as células de Purkinje. Os animais adultos apresentaram aumentos mais proeminentes no sistema VEGF/Flt-1/Flk-1 do cerebelo do que os recémnascidos; nestes, o PNV induziu diminuição na expressão da Ocludina, ?-catenina e Laminina, enquanto nos adultos a diminuição ocorreu apenas na Ocludina e ?-catenina. O veneno da aranha P. nigriventer contem peptídeos neurotóxicos que causam excitabilidade na neurotransmissão nervosa por modificarem a fisiologia dos canais de sódio, potássio e cálcio. Uma vez que a dinâmica das alterações descritas diferiu entre regiões cerebrais e entre animais neonatos e adultos jovens, sugerimos particularidades regionais e de funcionalidade, tanto da BHE, como dos neurônios imunorreativos em resposta ao PNV. Estes resultados são os primeiros a demonstrar alterações do sistema VEGF/Flt-1/Flk-1 no hipocampo e cerebelo que cursam com sinais neuroexcitotóxicos dos animais que foram tratados com o veneno / Abstract: Vascular endothelial growth factor (VEGF), a major regulator of developmental angiogenesis and vascular permeability, was recently recognized as neurotrophic, neurogenic and neuroprotector, hence being upregulated in many neuropathological processes. In this experimental model of blood brain barrier (BBB) breakdown by the Phoneutria nigriventer spider venom (PNV), the expression of VEGF and its receptor tyrosine kinases, Flt-1 and Flk-1 and their mRNAs was investigated in the hippocampus and cerebellum of Wistar rats (Rattus norvegicus) by immunohistochemistry (IHC), western blotting (WB) and real time polymerase chain reaction (qPCR). Simultaneously, the BBB integrity was assessed through expression of paracellular pathway proteins, ?- catenin and Occludin, and the main basement membrane protein, Laminin, which are present in the endothelium blood-brain interface. The study was performed in rats by 14 days (neonates) and 8-10 weeks (young adults) to assess differences related to age in the BBB functionality and the possible mediation of the PNV neurotoxic effects by VEGF. The via chosen for PNV administration (1.7 mg/kg in 0.5 ml of 0.9% saline) was intraperitoneally, due to more favorable application in neonate animals. The times of 2, 5 and 24 hours after PNV administration aimed to investigate the expression of proteins, mRNAs, and possible mediation by VEGF in acute envenomation. The PNV administration provoked immediate signs of intoxication in animals, which were more severe and immediate in neonates than in adults. In hippocampus, the WB data showed increased expression of VEGF, Flt-1 and Flk-1 and their mRNAs, which were concomitant with the development of perivascular edema, and decreased expression of Occludin, ?-catenin and Laminin. IHC data show that VEGF immunoreactivity occurred in the bodies and dendrites of pyramidal neurons in the subfield CA1, CA2, CA3 and dentate gyrus of the hippocampus, in contrast with nuclear staining of Flt-1 and Flk-1. The PNV visibly increased immunostaining of the three proteins. In cerebellum, the WB data and IHC showed that the PNV induced an increase in the expression of VEGF/Flt-1/Flk-1 system components. Cells in the granular and molecular layer showed no marking in the control animals became positive in animals envenomed, especially Purkinje cells. Adult animals showed increases more prominent in the VEGF/Flt-1/Flk-1 system of the cerebellum than xx neonates; in these animals, the PNV induced decrease in expression of Occludin, ?-catenin and Laminin, while in adults the decrease occurred only in Occludin and ?-catenin. The venom of the spider P. nigriventer contains peptides that cause excitability in the nervous neurotransmission by modifying the physiology of sodium, potassium and calcium channels. Since the dynamics of the changes described differed between brain regions and among neonates and young adult animals, we suggest regional specificities and functionality of BHE and immunoreactive neurons in response to PNV. These results are the first to demonstrate changes in the hippocampus and cerebellum VEGF/Flt-1/Flk-1 system that courses with neuroexcitotoxic signs of animals that were treated with venom / Mestrado / Farmacologia / Mestra em Farmacologia

Abstract Phosphatidylethanol (PEth) is an abnormal phospholipid formed only in the presence of ethanol. Ethanol causes changes in the concentration and composition of plasma lipoproteins and it also influences the enzymes and transfer proteins that modify lipoproteins in plasma. PEth might be one of these changes brought on by ethanol in the circulation. The present study was designed to investigate whether qualitative changes in high density lipoprotein (HDL) phospholipids caused by ethanol can mediate the beneficial effects of alcohol on atherosclerosis, and to investigate the transfer of PEth between lipoproteins and the effects of PEth on the charge of lipoprotein particles. PEth was shown to be transferred from low density lipoproteins (LDL) to HDL particles mainly by transfer proteins other than cholesteryl ester transfer protein (CETP). The transfer of PEth between lipoproteins enables the redistribution of PEth between lipoproteins in plasma. The results of this study provide evidence that PEth in HDL particles stimulates the vascular endothelial growth factor (VEGF) secretion from vascular wall cells. The increase in the secretion was mediated through protein kinase C (PKC) and mitogen-activated protein kinase (MAPK) signalling pathways. PEth-containing HDL particles were able to increase the VEGF secretion in rats in vivo. Similar effects were also observed when rats were given HDL particles isolated from the plasma of alcoholics. The PEth-induced change in the electrical charge of lipoproteins may affect the binding of lipoproteins to their receptors and binding proteins. The effects of PEth on the secretion of VEGF from the endothelial cells were shown to be mediated through HDL receptor. The changes in HDL particles caused by phosphatidylethanol may modify the metabolism of lipoproteins and lipid-mediated signalling pathways regulating VEGF in vascular wall cells.

Prognostic factors come in a variety of forms and may be patient, tumour or environmental related. This thesis examines the interaction of prognostic factors for a variety of tumour types. It particularly focuses on single nucleotide polymorphisms (SNPs) of the vascular endothelial growth factor (VEGF) gene. The first section on meningiomas describes the frequency of sex steroid receptors in meningiomas. In this study, absence of progesterone receptors is associated with high tumour grade and male gender. Tumours that are progesterone receptor negative have an odds ratio for recurrence of 5.Choroid plexus carcinomas are aggressive malignant tumours generally occurring in young children. Gross total surgical resection has been shown to be a highly significant factor in tumour recurrence and survival. This study describes a treatment paradigm of neoadjuvant ICE chemotherapy in these children which decreases the vascularity and increase the chance of a complete removal. The operative blood loss with this regimen is reduced to 0.22 blood volumes from 1.11 blood volumes without neoadjuvant chemotherapy. The VEGF gene is highly polymorphic and SNPs of the region have previously been shown to influence VEGF protein expression. This study looks at cohorts of both adult gliomas and a variety of paediatric brain tumours; comparing them to controls. There are several associations described between the development of certain tumours and specific SNP genotypes. In addition to this, certain genotypes and haplotypes have an influence on survival of adult grade 2 astrocytomas and paediatric medulloblastomas and ependymomas. There are consistent themes to the prognostic genotypes throughout both the adult and the paediatric tumours.Prognostic factors come in a variety forms as described in this thesis. It is vital to understand the complex interaction between factors to best utilise them for the benefit of patients.

Despite of all the research going on for the treatment of ocular diseases, age-related macular degeneration (AMD) remains one of the serious vision threatening disease worldwide. Choroidal neovascularization, a pathophysiological characteristic of wet AMD, is the growth of anomalous blood vessels in the eye choroidal layer. Neovascularization is a key factor in AMD and thus anti-angiogenic therapy is beneficial in reducing the development of new abnormal blood vessels to prevent progression of AMD. Axitinib, multi-receptor tyrosine kinase inhibitor, is a small molecule that works by blocking vascular endothelial growth factor receptors (VEGFR) and platelet derived growth factor receptors (PDGFR) responsible for developing neovascularization. Thus, goal of this study was to develop and characterise a sustained release formulation of Axitinib loaded poly (lactic-co-glycolic) acid (PLGA) nanoparticles. The nanoparticles were characterized for particle size and zeta potential as well as using DSC, TEM and in vitro drug release profile. The cytotoxicity of the formulation was evaluated on human retinal pigmented epithelium ARPE19 cells by MTT assay. The cellular uptake, anti-migration assay, and VEGF expression levels were found out in vitro using cells. The optimized formulation was 131.33 ± 31.20 nm in size with -4.63± 0.76 mV zeta potential. Entrapment efficiency was found to be 87.9 ± 2.7%. The cytotoxicity of ARPE19 cells was less than 12% for nanoparticles suggesting the in vitro compatibility at 10 µM concentration of drug. Cellular uptake, anti-migration assay and VEGF expression levels for the nanoparticles had greater uptake, had significant anti-angiogenic potential and exhibited inhibition of VEGF activity. The results showed successful development of axitinib loaded PLGA nanoparticles as an alternative potential treatment option for AMD.

Magister Scientiae (Medical Bioscience) - MSc(MBS) / Cancer is a global health catastrophe, with neuroblastoma, the most common solid childhood tumor, and glioblastoma, a deadly brain tumor, being aggressive and unresponsive to current treatment modalities. These tumors are known to utilize uncontrollable cell proliferative capabilities as a mechanism for tumor survival. Therefore, malignant cell growth can be mitigated by targeting the essential proteins that regulate cell growth, such as receptor tyrosine kinases (RTKs). Under normal physiological conditions, RTKs bind with varying affinity to mitogenic stimuli such as growth factors such as vascular endothelial growth factor (VEGF) and platelet-derived growth factor (PDGF) which, in turn, leads to receptor phosphorylation and activation.

Vascular endothelial growth factor (VEGF) is a potent mitogen for endothelial cells and a vascular permeability factor. In this study we found that the addition of angiotensin II (AII) to rat heart endothelial cells induced VEGF mRNA production. VEGF mRNA levels reached a plateau within 2 h after the addition of AII and decreased after 4 h. The induction was superinduced by cycloheximide and blocked by actinomycin D. Losartan, an AT1 receptor antagonist, abolished the induction of VEGF mRNA by AII, whereas PD 123319, an AT2 receptor antagonist, had no effect on VEGF mRNA induction. H7, a protein kinase C inhibitor, blocked the induction. RT-PCR experiments showed two mRNA species (VEGF 120 and VEGF 164) in these cells and both species were stimulated by AII. Transient transfection experiment showed that VEGF promoter activity was increased 2.2-fold upon AII stimulation. Electrophoretic mobility shift assay revealed an enhanced binding of transcription factors AP-1 and NF-KB. Immunoblot analysis showed that the amount of secreted VEGF was elevated in the medium 8 h after AII stimulation. Our results demonstrate for the first time that the upregulation of VEGF by AII may play a significant role in AII-induced hyperpermeability.

Aim: To explore the protective effects and involved mechanisms of two angiogenic growth factors, vascular endothelial growth factor (VEGF165) and angiopoietin-1 in cardiac myoblasts. Methods: Replication-deficient adenovirus encoding for human VEGF165 (Ad-VEGF165) or angiopoietin-1 (Ad-Ang1) were transfected into H9C2 cardiac myoblasts. Recombinant adenovirus encoding for green fluorescent protein (Ad-GFP) was used as vehicle control. Twenty-four hours later, cell apoptosis was induced by 300 μmmol of H2O2. Genomic DNA was extracted and DNA fragmentation was analyzed in 1.6% agarose gels. Phosphatidylinositol-3 kinase(PI-3 K) activity and bcl-2 expression level were investigated in H9C2 after gene transfection 24 hours later by an immol/Lunoprecipitated kinase assay and Western blot assay respectively. The effect of wartmannin, a specific inhibitor of PI-3 K, on DNA fragmentation, PI-3 K activity and bcl-2 expression was also analyzed by a pre-treatment of 30 minutes before transfection. Results: Apoptotic DNA fragmentation induced by H2O2 was significantly inhibited by the transfaction of Ad-VEGF165 and/or Ad-Ang1 but then aborted by the pretreatment of wartmannin. PI-3 K activity was significantly elevated after Ad-VEGF165 + Ad-Ang1 transfection as compared to Ad-GFP transfection group(2.60 vs 1.32, P < 0.01). Anti-apoptotic factor bcl-2 expression was upregulated in Ad-VEGF165 (2.1-fold), Ad-Ang1 (1.7-fold) and Ad-VEGF165 + Ad-Ang1 (1.7-fold) treated groups as compared to Ad-GFP transfection group. Wortmannin suppressed PI-3 K activiation induced by Ad-VEGF165 (from 1.83 to 0.69, P < 0.05). Ad-Ang1 (from 1.80 to 0.97, P = 0.07) or Ad-VEGF165a + Ad-Ang1 (from 2.60 to 0.42, P < 0.01). However, upregulation of bcl-2 induced by Ad-VEGF165 and/or Ad-Ang1 was not aborted by wortmannin pretreatment. Conclusions: VEGF165 and/or Ang1 can protect cardiac myoblasts from apoptosis induced by H2O2 throught PI-3 K and bcl-2 pathway. The anti-apoptotic function of either VEGF165 or Ang1 could be served as a now therapeutic target including their angiogenic benefits.

Aim: We aimed to clone angiopoietin-1 (Ang1) and vascular endothelial growth factor (VEGF) full-length DNAs of human origin and construct replication-deficient adenovirus encoding for either of these two genes which can be potentially served for clinical applications. Methods: VEGF165 and Ang1 full-length cDNAs of human origin were amplified by RT-PCR, verified by sequencing, cloned into a pShuttle-CMV vector, recombined with a E1 and E3 regions double-deleted adenovirus, packaged in 293A cells, and purified by ultracentrifugation. The titers of Ad-Ang1 and Ad-VEGF165 were determined by a tissue culture infectious dose50 method. Expression of Ang1 and VEGF165 proteins in H9C2 cardiac myoblasts was examined by Western blot. To examine the protective properties of Ad-Ang1 and Ad-VEGF165, DNA fragmentation induced by H2O2 was analyzed in H9C2 cells 24 hours after transfection. Ad-GFP served as a vehicle control. Results: Sequencing analysis indicated that there is one base difference at site 1206 (t) in Ang1 compared with that of GeneBank (c, U83508) although the coded amino acids are the same (Ileucine). VEGF165 cDNA sequence was same as that of GeneBank (AB021221). Western blot showed that protein levels of Ang1 and VEGF165 were increased 3.53 and 11.53 fold respectively 24 h after transfection as compared to control. Examination of DNA fragmentation suggested that Ang1 and/or VEGF165 significantly protected H9C2 cells from H2O2 induced apoptosis. Conclusions: The two constructed adenoviral vectors, Ad-Ang1 and Ad-VEGF165, functionally expressed target proteins. We demonstrated, for the first time, that the combined utilization of Ang1 and VEGF165 inhibited apoptosis, in addition to their angiogenesis properties.